News coverage about Burcon Nutrascience (NASDAQ:BUR) (TSE:BU) has trended somewhat negative this week, according to Accern. Accern scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Burcon Nutrascience earned a daily sentiment score of -0.14 on Accern’s scale. Accern also gave news articles about the biotechnology company an impact score of 46.9437163414938 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Shares of BUR traded up $0.52 on Tuesday, reaching $0.52. 177,300 shares of the company’s stock traded hands, compared to its average volume of 127,750. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 7.79. Burcon Nutrascience has a 52-week low of $0.38 and a 52-week high of $1.46.
Burcon Nutrascience (NASDAQ:BUR) (TSE:BU) last issued its quarterly earnings results on Friday, February 9th. The biotechnology company reported ($0.03) EPS for the quarter. The business had revenue of $0.01 million for the quarter. Burcon Nutrascience had a negative net margin of 3,417.46% and a negative return on equity of 255.87%.
About Burcon Nutrascience
Burcon NutraScience Corporation develops plant protein extraction and purification technology in the field of functional and renewable plant proteins. The company's patented processes utilize oilseed for the production of purified plant proteins that exhibit nutritional, functional, and nutraceutical profiles.
Receive News & Ratings for Burcon Nutrascience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon Nutrascience and related companies with MarketBeat.com's FREE daily email newsletter.